Latest news
New Updates in Drug Formulation and Bioavailability
Iconovo´s CEO Dr Orest Lastow will be moderating the New Updates in Drug Formulation and Bioavailability conference in Copenhagen 7 April. Formulation…
Computational Fluid Dynamics, CFD
Iconovo has invested in the Autodesk Simulation CFD software. Iconovo CEO Dr Orest Lastow was previously head of the AstraZeneca CFD group and has long…
Press releases
Jul 01, 2021, 22:06
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
May 26, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 26, 2021, 08:00
News
IR
English
Corporate Information
Other Corporate Information
May 24, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
May 20, 2021, 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 20, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
May 19, 2021, 10:07
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 17, 2021, 10:45
News
IR
Swedish
Corporate Information
Other Corporate Information
May 17, 2021, 10:45
News
IR
English
Corporate Information
Other Corporate Information
May 14, 2021, 07:05
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 14, 2021, 07:05
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Apr 30, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Apr 29, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 28, 2021, 08:35
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 27, 2021, 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 27, 2021, 09:30
News
IR
English
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
